These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17599040)

  • 21. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
    Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
    Su N; Qiu H; Chen Y; Yang T; Yan Q; Wan X
    Oncol Rep; 2013 Jun; 29(6):2297-302. PubMed ID: 23589079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
    Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
    Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
    Kyo S; Sakaguchi J; Kiyono T; Shimizu Y; Maida Y; Mizumoto Y; Mori N; Nakamura M; Takakura M; Miyake K; Sakamoto M; Inoue M
    Clin Cancer Res; 2011 Feb; 17(3):525-37. PubMed ID: 21131554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of the FOXO1, KLF9 and YT521 genes expression in human endometrial cancer.
    Korani M; Fallah S; Tehranian A; Nourbakhsh M; Samadikuchaksaraei A; Pour MS; Maleki J
    Clin Lab; 2013; 59(5-6):483-9. PubMed ID: 23865345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.
    Haughian JM; Bradford AP
    J Cell Physiol; 2009 Jul; 220(1):112-8. PubMed ID: 19235902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
    Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
    Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway.
    Jiang J; Zhang C; Wang J; Zhu Y; Wang X; Mao P
    Anticancer Agents Med Chem; 2023; 23(19):2127-2134. PubMed ID: 37670696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.
    Takano M; Lu Z; Goto T; Fusi L; Higham J; Francis J; Withey A; Hardt J; Cloke B; Stavropoulou AV; Ishihara O; Lam EW; Unterman TG; Brosens JJ; Kim JJ
    Mol Endocrinol; 2007 Oct; 21(10):2334-49. PubMed ID: 17609436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
    Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
    Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization.
    Kajihara T; Jones M; Fusi L; Takano M; Feroze-Zaidi F; Pirianov G; Mehmet H; Ishihara O; Higham JM; Lam EW; Brosens JJ
    Mol Endocrinol; 2006 Oct; 20(10):2444-55. PubMed ID: 16709600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel wnt regulatory axis in endometrioid endometrial cancer.
    Zhao Y; Yang Y; Trovik J; Sun K; Zhou L; Jiang P; Lau TS; Hoivik EA; Salvesen HB; Sun H; Wang H
    Cancer Res; 2014 Sep; 74(18):5103-17. PubMed ID: 25085246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
    Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
    Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.